Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Keros Corp (KROS)

Logo perusahaan publik kerostx.com (KROS)

The low predictability of Keros Therapeutics (KROS) cash flows is driven by its laboratory research stage, which is confirmed by the EV/EBITDA value including total debt shown on this GURU.Markets chart, where 0.00 captures the current state of the parameter. Profit prospects are based on therapies for anemia and bone pathologies, while investment inflows rely on clinical data under full FDA oversight.

Keros Therapeutics Inc - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan KROS (periode 23.11.2025 - 15.11.2026)

Rincian metrik komprehensif lan analitis Keros Therapeutics Inc (KROS)

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental:Keros Therapeutics KROS
Produk sing diprodhuksi Keros Therapeutics, Inc.

Assessing the investment reliability of equity assets begins with analyzing the ratio of total enterprise value to operating profit before depreciation and interest. For Keros Therapeutics (KROS), which is developing a TGF-beta protein modulation platform, the company's EV/EBITDA value on this chart reflects the efficiency of capitalizing innovations in rare disease therapy, allowing for a determination of the asset's overvaluation relative to its actual cash flow.

Pesaing wigati

Pangali EV/EBITDA VRTX (vrtx.com)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Alnylam (ALNY)|INSM: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan UTHR|BMRN: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BridgeBio Pharma Inc (BBIO)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BGM|Nilai perusahaan marang bathi operasional sadurunge panyusutan COGT (Cogent Biosciences, Inc.)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan XERS (Xeris Biopharma Holdings)|ARCT (Arcturus Therapeutics Inc) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Eton Pharmaceuticals, Inc. ETON|KMDA (Kamada Corp) - Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan|Fulcrum Therapeutics - Pangali EV/EBITDA|Nilai bisnis marang bathi operasional sadurunge panyusutan ABEO (abeonatherapeutics.com)|MREO: Pangali EV/EBITDA|Protalix BioTherapeutics Inc. - Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan pliantrx.com|APLT: Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan aileronrx.com (RNTX)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Gelteq GELS|Pangali EV/EBITDA AYTU (Aytu BioPharma Inc)|Pangali EV/EBITDA Chemomab CMMB|SRXH - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan PLRZ|AEZS: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cyclo Therapeutics (CYTH)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Inozyme Pharma Inc.|Nilai perusahaan marang bathi operasional sadurunge panyusutan RPHM (Reneo Pharmaceuticals, Inc.)|Pangali EV/EBITDA CSCI